Close Menu

NEW YORK (GenomeWeb) — InDevR said today that it has received 510(k) clearance from the US Food and Drug Administration for its FluChip-8G Influenza A+B assay.

The RT-PCR-based in vitro diagnostic is designed to detect whole gene segments for influenza A and B viruses in order to identify and differentiate them. A machine learning algorithm then identifies the signal pattern of specific target virus groups to help characterize infections as seasonal or nonseasonal.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
13

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jun
19

This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.